Cargando…
Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104342/ https://www.ncbi.nlm.nih.gov/pubmed/33686995 http://dx.doi.org/10.4103/lungindia.lungindia_568_20 |
| _version_ | 1783689474698379264 |
|---|---|
| author | Marwah, Vikas Choudhary, Robin Bhati, Gaurav Peter, Deepu K |
| author_facet | Marwah, Vikas Choudhary, Robin Bhati, Gaurav Peter, Deepu K |
| author_sort | Marwah, Vikas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8104342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81043422021-05-12 Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation Marwah, Vikas Choudhary, Robin Bhati, Gaurav Peter, Deepu K Lung India Research Letters Wolters Kluwer - Medknow 2021-03 2021-03-06 /pmc/articles/PMC8104342/ /pubmed/33686995 http://dx.doi.org/10.4103/lungindia.lungindia_568_20 Text en Copyright: © 2021 Lung India https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Research Letters Marwah, Vikas Choudhary, Robin Bhati, Gaurav Peter, Deepu K Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation |
| title | Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation |
| title_full | Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation |
| title_fullStr | Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation |
| title_full_unstemmed | Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation |
| title_short | Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation |
| title_sort | early experience with anti-interleukin-6 therapy in covid-19 hyperinflammation |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104342/ https://www.ncbi.nlm.nih.gov/pubmed/33686995 http://dx.doi.org/10.4103/lungindia.lungindia_568_20 |
| work_keys_str_mv | AT marwahvikas earlyexperiencewithantiinterleukin6therapyincovid19hyperinflammation AT choudharyrobin earlyexperiencewithantiinterleukin6therapyincovid19hyperinflammation AT bhatigaurav earlyexperiencewithantiinterleukin6therapyincovid19hyperinflammation AT peterdeepuk earlyexperiencewithantiinterleukin6therapyincovid19hyperinflammation |